Apdime T 250mg/31.25mg Injection
Marketer
Apkavit Lifesciences
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Apdime T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be under medical guidance; strict adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise its effectiveness. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate urgent medical care. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if experiencing somnolence or vertigo. Ample rest, proper nutrition, and hydration are vital for optimal recovery. Your physician may order tests to monitor the medication's impact.
Uses of Apdime T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Apdime T 250mg/31.25mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
Common Side effects of Apdime T 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Apdime T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Apdime T 250mg/31.25mg Injection works:
Apdime T Injection (250mg/31.25mg) combines the antibiotic ceftazidime with the beta-lactamase inhibitor tazobactam. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counters bacterial resistance, thereby boosting ceftazidime's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Apdime T 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Apdime T 250mg/31.25mg Injection is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to the fetus; nonetheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Apdime T 250mg/31.25mg injections are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
The injection Apdime T 250mg/31.25mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Apdime T 250mg/31.25mg Injection. A modified dosage of Apdime T 250mg/31.25mg Injection may be necessary. Physician consultation is advised.
LiverCAUTION
Apdime T 250mg/31.25mg Injection requires careful administration in individuals suffering from significant hepatic impairment. Dosage modification of Apdime T 250mg/31.25mg Injection might be necessary. Medical advice is recommended.
What if you forget to take Apdime T 250mg/31.25mg Injection :
Should you forget to take a scheduled dose of Apdime T 250mg/31.25mg Injection, seek advice from your physician.
Facts to Know About Apdime T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Category | Agents against infection |
3,018 People bought this recently